What is the optimal free trial length for B2B SaaS?

There is no universal optimal trial length — the right duration is long enough for users to experience core value at least twice, but short enough to create urgency to convert. For most B2B SaaS products, 14 days is the most common choice and works well when the product has a fast time-to-value (under 2 hours to first meaningful outcome). Products with complex setup, long sales cycles, or workflows that require team adoption often perform better with 30-day trials. Trials longer than 30 days rarely improve conversion and often reduce urgency.

Should I use a 14-day or 30-day free trial?

Use a 14-day trial if your product has fast time-to-value and users can complete a meaningful workflow within 2–3 sessions. Use a 30-day trial if your product requires multi-stakeholder buy-in, involves a lengthy data import or configuration process, or has workflows that naturally occur on a weekly rather than daily basis. The decision should be driven by time-to-value data — if 80% of users who eventually convert do so within 14 days, extending to 30 days adds complexity without improving conversion. If a meaningful portion of conversions happen in days 15–30, extending the trial is justified.

What is time-to-value (TTV) and how does it affect trial length?

Time-to-value (TTV) is the elapsed time between a user signing up and experiencing the core value of the product for the first time — the aha moment. TTV directly determines appropriate trial length: your trial should be at least 3–5x your median TTV so that activated users have time to experience value repeatedly before the trial ends. A product with a 30-minute TTV can work well with a 7-day trial; a product with a 3-day TTV likely needs 21–30 days minimum. Reducing TTV is often more effective than extending trial length because it also improves activation rates.

How do I know if my trial is too short?

Your trial is too short if a significant percentage of trial users are requesting extensions before converting, if conversion rates increase noticeably when you manually extend specific users' trials, or if exit surveys from non-converting trials cite 'not enough time' as a primary reason. You can also look at activation timing: if 30%+ of users who eventually reach your activation event do so in the final 20% of the trial window, many of them may be running out of time before they can decide to convert. Compare this to users who activated early in the trial — they typically convert at 2–3x the rate.

What is the conversion rate from free trial to paid for B2B SaaS?

Free-trial-to-paid conversion rates for B2B SaaS typically range from 15–25% for opt-in trials (no credit card required) and 40–60% for opt-out trials (credit card required at signup). The wide variance reflects how much self-selection differs between models: opt-out trials attract fewer sign-ups but much higher intent. Product-led growth benchmarks from OpenView consistently show that activated trial users — those who reached the core activation event — convert at 3–5x the rate of non-activated trial users, which is why improving activation during trial is the highest-leverage conversion lever.

Free Trial Length Calculator — What's the Right Trial Period for Your SaaS?

Your Trial Length Should Match Your Activation Pattern

The right trial length is determined by your product's time-to-value, not by what competitors do. If your product can show a meaningful result in 20 minutes, a 30-day trial doesn't help — it delays the conversion decision. If your product requires 3 weeks of usage data to show its value, a 14-day trial sets users up to fail.

What the Data Says About Trial Lengths

According to ChartMogul's analysis of SaaS products in 2026, 62% use 14-day trials, 14% use 7-day trials, and 14% use 30-day trials. But the most successful trial length depends on your specific activation pattern.

Trial Length	Best For	Typical ACV	Key Risk
7 days	Simple products with immediate TTV	< $1K/yr	Users may not have time to explore
14 days	Most B2B SaaS products	$1K–$5K/yr	Default choice without thinking about TTV
30 days	Complex products requiring setup	$5K–$25K/yr	Users lose urgency, coast to expiry
No limit / Freemium	Products with viral or network effects	Varies	High infrastructure cost per free user

The insight: Time-based and usage-based trials convert roughly 2x better than feature-limited or seat-limited trials. The trial structure matters more than the trial length.

The Problem With 14-Day Trials

Most teams default to 14 days without measuring whether users actually receive value within that window. Before shortening or lengthening your trial, instrument time-to-first-value: how long does it take for users to complete the action that most strongly predicts conversion? That number is your minimum viable trial length.

50% → 34%

Trial-to-paid median conversion dropped from 50% (2023) to 34% (2025) across SaaS — a 32% decrease. Source: Recurly analysis of 2,200+ brands. The teams winning at trial conversion are those that actively manage the trial experience, not just its length.

The Reverse Trial: The 2026 Gold Standard

The emerging best practice is the "Reverse Trial": start users on full Pro access for 14 days, then "downgrade" them to a limited free tier at the end of the trial period rather than cutting off access entirely. This approach converts at 20%+ — outperforming both traditional free trials and freemium.

Opt-in billing (no credit card required) converts at 18.2% trial-to-paid. Opt-out billing (credit card required) converts at 48.8%. But opt-out also creates lower-intent signups and higher support costs.

"B2B 7-day conversion rates sit around 2.5%. By day 14, both drop to approximately 1%. The window does not stay open long — the trial experience within those first days matters more than the total trial length."

— Kirro, SaaS Conversion Rate Benchmarks 2026

The cancellation button is a lagging indicator. The first signals appear in product usage data, days or weeks before anyone knows they're looking at a non-converting trial.

Free Resource

Read: Free Trial vs Freemium

The 2026 decision framework for choosing between Free Trial, Freemium, and the Reverse Trial based on your ACV, TTV, and unit economics.

Read the Article → Trial Length Deep-Dive

Related Offer

Get Your Full GTM Foundations Reviewed

Trial length is one input. ProductQuant's Foundation engagement reviews your full acquisition-to-activation funnel and identifies the highest-leverage fix.

Fix Your Entire Onboarding-to-Paid System → Book a Free Call

For teams building their PLG motion, the PLG topic page covers the full framework, and PLG Metrics That Actually Matter explains which trial metrics to track beyond conversion rate.

Frequently Asked Questions

What's the best trial length for SaaS?

It depends on your time-to-value. If users get value in minutes, 7 days is enough. For most B2B SaaS, 14 days works. For complex products requiring data import or setup, 30 days may be justified. Measure your time-to-first-value to decide.

Why are trial-to-paid conversion rates dropping?

Trial-to-paid median dropped from 50% (2023) to 34% (2025). This is driven by increased competition, longer evaluation cycles, and users testing more products simultaneously. The teams winning are those that actively manage the trial experience.

What is a Reverse Trial?

A Reverse Trial starts users on full Pro access and then 'downgrades' them to a limited free tier at the end of the trial period, rather than cutting off access. It converts at 20%+ and is becoming the 2026 gold standard for B2B SaaS.

Should I require a credit card for trials?

Credit card required (opt-out) converts at 48.8% but creates lower-intent signups. No credit card (opt-in) converts at 18.2% but attracts higher-quality leads. The choice depends on your ACV and sales motion.

How do I know if my trial length is wrong?

If most users convert within the first 3-5 days, your trial is probably longer than needed. If users consistently ask for extensions, it may be too short. Instrument time-to-first-value to make a data-driven decision.

Does trial structure matter more than length?

Yes. Time-based and usage-based trials convert roughly 2x better than feature-limited or seat-limited trials. A well-structured 7-day trial will outperform a poorly structured 30-day trial.

14 days or 30 days? Stop leaking trials to 'time-to-value' mismatch.